Company Filing History:
3 out of 6 
1 out of 4 Years Active: 2016-2019
Title: Joaquín Pastor Fernández: A Pioneer in Protein Kinase Inhibitor Innovations
Introduction
Joaquín Pastor Fernández, based in Madrid, Spain, is a notable inventor with a focus on breakthroughs in the field of biochemistry and oncology. With a total of four patents to his name, he stands at the forefront of research aimed at combating various diseases, including cancer.
Latest Patents
Among his most recent innovations are two significant patents in the realm of protein kinase inhibitors. The first, titled "Condensed Tricyclic Compounds as Protein Kinase Inhibitors," presents compounds structured with specific formula components that are beneficial in treating diseases where inhibition of protein or lipid kinases such as CDK8 and Haspin kinase is crucial. These compounds aim primarily at aiding in cancer treatment.
The second patent, "Macrocyclic Compounds as Protein Kinase Inhibitors," similarly introduces compounds formulated to inhibit key kinases like PI3-K and mTOR, instrumental in various oncological applications. This invention also covers combinations of these compounds, reinforcing their potential in therapeutic settings.
Career Highlights
Joaquín has made significant contributions to research through his work at prestigious institutions. He has been affiliated with the Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III, as well as the Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, both of which are instrumental in advancing cancer research in Spain.
Collaborations
Throughout his career, Joaquín has collaborated with esteemed colleagues, including Sonia Martínez González and Carmen Blanco Aparicio. These collaborations have enriched his research endeavors, leading to remarkable advancements in the understanding and treatment of proliferative diseases.
Conclusion
Joaquín Pastor Fernández exemplifies the innovative spirit of the life sciences sector. His patents contribute significantly to the treatment of cancer, showcasing the critical role of inventors in shaping the future of medical therapeutics. As the field of oncology continues to evolve, Joaquín's work stands as a testament to the impact that dedicated research and innovation can have on health and patient care.